BIO-key International (NASDAQ:BKYI) Announces Earnings Results

BIO-key International (NASDAQ:BKYI) released its quarterly earnings results on Thursday. The technology company reported ($0.56) earnings per share for the quarter, topping the consensus estimate of ($0.82) by $0.26, FiscalAI reports. BIO-key International had a negative return on equity of 70.21% and a negative net margin of 60.59%.The company had revenue of $1.92 million for the quarter, compared to analysts’ expectations of $1.80 million.

BIO-key International Stock Up 0.3%

NASDAQ:BKYI traded up $0.01 during trading hours on Thursday, hitting $3.77. 44,156 shares of the company traded hands, compared to its average volume of 167,494. The firm’s 50-day simple moving average is $4.37 and its 200-day simple moving average is $5.27. BIO-key International has a one year low of $3.10 and a one year high of $19.70. The company has a market cap of $4.11 million, a PE ratio of -0.68 and a beta of 0.44.

Analysts Set New Price Targets

A number of analysts recently weighed in on BKYI shares. Zacks Research upgraded BIO-key International to a “hold” rating in a report on Thursday, August 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a research note on Friday, July 17th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Reduce”.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC boosted its stake in shares of BIO-key International Inc. (NASDAQ:BKYI) by 49.9% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 48,892 shares of the technology company’s stock after buying an additional 16,271 shares during the quarter. Geode Capital Management LLC owned approximately 0.45% of BIO-key International worth $26,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 26.51% of the company’s stock.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.